Bleeding and Clotting Disorders

Return to all Chronic Conditions sessions.

Estimated time to complete session: 60 min.

Learning Objectives

Upon completion of this session, you should be able to:

1. Apply case-based learning to the etiology, differentiation and management of bleeding disorders in patients with unexplained bleeding. 
2. Develop a treatment/management plan for patients with hemophilia A and other rare bleeding disorders, including new and emerging recombinant products, in accordance with the most recent evidence-based recommendations. 
3. Choose appropriate anticoagulant therapy based on disease specific recommendations for outpatient management. 
4. Provide patient education regarding the FDA REMS guidelines for the use of rivaroxaban (Xarelto).

Additional Information

Technical Requirements: 

View technical requirements (opens in a new window).

CME Credit Information: 

View CME credit information (opens in a new window).

Disclosures: 

View disclosures and disclaimers (opens in a new window).

Course summary
Available credit: 
  • 1.00 AAFP prescribed
Course opens: 
01/17/2017
Course expires: 
01/16/2020
Parent activity set: 

David T Walsworth, MD, FAAFP, Associate Chair for Clinical Affairs; Associate Professor, Department of Family Medicine, College of Human Medicine, Michigan State University, East Lansing, Michigan

Available Credit

  • 1.00 AAFP prescribed

Accreditation Period

Course opens: 
01/17/2017
Course expires: 
01/16/2020
Please login or register to take this course.